I-E+ nonobese diabetic mice develop insulitis and diabetes

doi:10.1084/jem.178.3.793

This Article

	Full Text (PDF, 2580K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Podolin, P. L.
	Articles by Wicker, L. S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Podolin, P. L.
	Articles by Wicker, L. S.


Social Bookmarking

	What's this?

ARTICLES

I-E+ nonobese diabetic mice develop insulitis and diabetes

PL Podolin, A Pressey, NH DeLarato, PA Fischer, LB Peterson and LS Wicker
Department of Autoimmune Diseases Research, Mercke Research Laboratories, Rahway, New Jersey 07065.

The development of type I diabetes in the nonobese diabetic (NOD) mouse is under the control of multiple genes, one or more of which is linked to the major histocompatibility complex (MHC). The MHC class II region has been implicated in disease development, with expression of an I-E transgene in NOD mice shown to provide protection from insulitis and diabetes. To examine the effect of expressing an I-E+ or I-E- non-NOD MHC on the NOD background, three I-E+ and three I-E- NOD MHC congenic strains (NOD.H-2i5, NOD.H-2k, and NOD.H-2h2, and NOD.H-2h4, NOD.H-2i7, and NOD.H-2b, respectively) were developed. Of these strains, both I-E+ NOD.H-2h2 and I-E- NOD.H-2h4 mice developed insulitis, but not diabetes. The remaining four congenic strains were free of insulitis and diabetes. These results indicate that in the absence of the NOD MHC, diabetes fails to develop. Each NOD MHC congenic strain was crossed with the NOD strain to produce I-E+ and I-E- F1 mice; these mice thus expressed one dose of the NOD MHC and one dose of a non-NOD MHC on the NOD background. While a single dose of a non-NOD MHC provided a large degree of disease protection to all of the F1 strains, a proportion of I-E+ and I-E- F1 mice aged 5-12 mo developed insulitis and cyclophosphamide-induced diabetes. When I-E+ F1 mice were aged 9-17 mo, spontaneous diabetes developed as well. These data are the first to demonstrate that I-E+ NOD mice develop diabetes, indicating that expression of I-E in NOD mice is not in itself sufficient to prevent insulitis or diabetes. In fact, I-E- F1 strains were no more protected from diabetes than I-E+ F1 strains, suggesting that other non-NOD MHC- linked genes are important in protection from disease. Finally, transfer of NOD bone marrow into irradiated I-E+ F1 recipients resulted in high incidences of diabetes, indicating that expression of non-NOD MHC products in the thymus, in the absence of expression in bone marrow- derived cells, is not sufficient to provide protection from diabetes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Guimont-Desrochers, F., Cappello, Z. J., Chagnon, M., McDuffie, M., Lesage, S. (2009). Cutting Edge: Genetic Characterization of IFN-Producing Killer Dendritic Cells. J. Immunol. 182: 5193-5197 [Abstract] [Full Text]
Nakahara, M., Nagayama, Y., Saitoh, O., Sogawa, R., Tone, S., Abiru, N. (2009). Expression of Immunoregulatory Molecules by Thyrocytes Protects Nonobese Diabetic-H2h4 Mice from Developing Autoimmune Thyroiditis. Endocrinology 150: 1545-1551 [Abstract] [Full Text]
Yu, S., Sharp, G. C., Braley-Mullen, H. (2008). TGF-{beta} Promotes Thyroid Epithelial Cell Hyperplasia and Fibrosis in IFN-{gamma}-Deficient NOD.H-2h4 Mice. J. Immunol. 181: 2238-2245 [Abstract] [Full Text]
Yu, S., Dunn, R., Kehry, M. R., Braley-Mullen, H. (2008). B Cell Depletion Inhibits Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice. J. Immunol. 180: 7706-7713 [Abstract] [Full Text]
Yu, S., Sharp, G. C., Braley-Mullen, H. (2006). Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia. J. Immunol. 176: 1259-1265 [Abstract] [Full Text]
Sharma, R. B., Alegria, J. D., Talor, M. V., Rose, N. R., Caturegli, P., Burek, C. L. (2005). Iodine and IFN-{gamma} Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2h4 Mouse Thyrocytes. J. Immunol. 174: 7740-7745 [Abstract] [Full Text]
Wei, Y., Chen, K., Sharp, G. C., Braley-Mullen, H. (2004). Fas Ligand Is Required for Resolution of Granulomatous Experimental Autoimmune Thyroiditis. J. Immunol. 173: 7615-7621 [Abstract] [Full Text]
Barin, J. G., Afanasyeva, M., Talor, M. V., Rose, N. R., Burek, C. L., Caturegli, P. (2003). Thyroid-Specific Expression of IFN-{gamma} Limits Experimental Autoimmune Thyroiditis by Suppressing Lymphocyte Activation in Cervical Lymph Nodes. J. Immunol. 170: 5523-5529 [Abstract] [Full Text]
Brook, F. A., Evans, E. P., Lord, C. J., Lyons, P. A., Rainbow, D. B., Howlett, S. K., Wicker, L. S., Todd, J. A., Gardner, R. L. (2003). The Derivation of Highly Germline-Competent Embryonic Stem Cells Containing NOD-Derived Genome. Diabetes 52: 205-208 [Abstract] [Full Text]
Lesage, S., Hartley, S. B., Akkaraju, S., Wilson, J., Townsend, M., Goodnow, C. C. (2002). Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune Diabetes. JEM 196: 1175-1188 [Abstract] [Full Text]
Yu, S., Sharp, G. C., Braley-Mullen, H. (2002). Dual Roles for IFN-{gamma}, But Not for IL-4, in Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice. J. Immunol. 169: 3999-4007 [Abstract] [Full Text]
Prasad, S. J., Goodnow, C. C. (2002). Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int Immunol 14: 677-684 [Abstract] [Full Text]
Thiessen, S., Serra, P., Amrani, A., Verdaguer, J., Santamaria, P. (2002). T-Cell Tolerance by Dendritic Cells and Macrophages as a Mechanism for the Major Histocompatibility Complex-Linked Resistance to Autoimmune Diabetes. Diabetes 51: 325-338 [Abstract] [Full Text]
Trembleau, S., Gregori, S., Penna, G., Gorny, I., Adorini, L. (2001). IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule. J. Immunol. 167: 4104-4114 [Abstract] [Full Text]
Lesage, S., Goodnow, C. C. (2001). Organ-specific Autoimmune Disease: A Deficiency of Tolerogenic Stimulation. JEM 194: F31-F36 [Full Text]
Braley-Mullen, H., Yu, S. (2000). Early Requirement for B Cells for Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice. J. Immunol. 165: 7262-7269 [Abstract] [Full Text]
Figueroa, D. J., Hess, J. F., Ky, B., Brown, S. D., Sandig, V., Hermanowski–Vosatka, A., Twells, R. C. J., Todd, J. A., Austin, C. P. (2000). Expression of the Type I Diabetes-associated Gene LRP5 in Macrophages, Vitamin A System Cells, and the Islets of Langerhans Suggests Multiple Potential Roles in Diabetes. J. Histochem. Cytochem. 48: 1357-1368 [Abstract] [Full Text]
Gregori, S., Trembleau, S., Penna, G., Gallazzi, F., Hammer, J., Papadopoulos, G. K., Adorini, L. (1999). A Peptide Binding Motif for I-Eg7, the MHC Class II Molecule That Protects E{alpha}-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes. J. Immunol. 162: 6630-6640 [Abstract] [Full Text]
Ridgway, W. M., Ito, H., Fasso, M., Yu, C., Garrison Fathman, C. (1998). Analysis of the Role of �Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response. JEM 188: 2267-2275 [Abstract] [Full Text]
Wicker, L. S. (1997). Major Histocompatibility Complex-linked Control of Autoimmunity. JEM 186: 973-975 [Full Text]
Schmidt, D., Verdaguer, J., Averill, N., Santamaria, P. (1997). A Mechanism for the Major Histocompatibility Complex-linked Resistance to Autoimmunity. JEM 186: 1059-1075 [Abstract] [Full Text]